Page last updated: 2024-09-05

erlotinib hydrochloride and Glomerulonephritis, Minimal Change

erlotinib hydrochloride has been researched along with Glomerulonephritis, Minimal Change in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chinda, J; Fujino, T; Hasebe, N; Kabara, M; Kuroshima, T; Maruyama, K; Nakagawa, N; Ogawa, Y; Ohsaki, Y; Yamamoto, Y	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Glomerulonephritis, Minimal Change

Article	Year
Minimal change nephrotic syndrome associated with gefitinib and a successful switch to erlotinib. Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:7 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Drug Substitution; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Nephrosis, Lipoid; Protein Kinase Inhibitors; Quinazolines	2015

Article

Year

Minimal change nephrotic syndrome associated with gefitinib and a successful switch to erlotinib.

Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:7

Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Drug Substitution; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Lung Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Nephrosis, Lipoid; Protein Kinase Inhibitors; Quinazolines

2015